Cystathionine beta-Synthase in hypoxia and ischemia/reperfusion: A current overview

• Published in: Archives of biochemistry and biophysics 2022-03, Vol.718, p.109149-109149, Article 109149
• Main Authors: Omorou, Moussa, Liu, Ning, Huang, Yiwei, Al-Ward, Hisham, Gao, Meng, Mu, Chenxi, Zhang, Lin, Hui, Xu
• Format: Article
• Language: English
• Subjects: Cystathionine beta-Synthase; Cystathionine beta-Synthase - metabolism; Cystathionine gamma-Lyase - metabolism; Homocysteine; Humans; Hydrogen sulfide; Hydrogen Sulfide - metabolism; Hypoxia; Ischemia; Reperfusion; Reperfusion Injury - metabolism
• ISSN: 0003-9861; 1096-0384
• DOI: 10.1016/j.abb.2022.109149

Besides its presence in the liver, brain, pancreas, and kidney, Cystathionine beta-Synthase (CBS) is also found in many other tissues, where it acts through regulation of hydrogen sulfide (H2S) generation and homocysteine (Hcy) metabolism, to interact with other molecules during hypoxia and ischemia/reperfusion (I/R). Despite all the advances accumulated in decades of research on CBS, there are still controversies, and the role of CBS in many tissues during hypoxia and I/R is still unclear. Herein, we overviewed the expression level, the role, and the mechanism through which CBS interacts with other molecules during hypoxia and I/R processes in tissues of humans and other organisms. CBS appeared to be deregulated under hypoxia and I/R, after which it mostly conduces the reparation in the concerned tissue after damage; however, it has been described that CBS could also play pathological effects (exacerbating the damage). From all findings, it emerges that variations in CBS expression in these conditions depend on the organism, tissue, or subcellular localization, CBS could play both protective and pathological effects; and artificially controlling CBS expression may help to provide novel strategies for treatment or prevention of hypoxia and I/R -related injury.